Targeting of erbB3 receptor to overcome resistance in cancer treatment

The erbB receptors, including the epidermal growth factor receptor (EGFR), erbB2 (also known as HER2/neu), erbB3 (or HER3), and erbB4 (or HER4), are often aberrantly activated in a wide variety of human cancers. They are excellent targets for selective anti-cancer therapies because of their transmem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jian, Lyu, Hui, Huang, Jingcao, Liu, Bolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022415/
https://www.ncbi.nlm.nih.gov/pubmed/24886126
http://dx.doi.org/10.1186/1476-4598-13-105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022415/
https://www.ncbi.nlm.nih.gov/pubmed/24886126
http://dx.doi.org/10.1186/1476-4598-13-105

Ejemplares similares